NCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
Clinical Trials
13 trialsNCT04910425 2025-10-21
PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
Northwestern University
Phase 2 Withdrawn
NCT04973007 2025-07-02
Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
University of Colorado, Denver
Phase 4 Terminated
NCT03703492 2025-02-12
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
University of Wisconsin, Madison
Phase 2 Completed
NCT04132843 2022-11-21
Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions
M.D. Anderson Cancer Center
Phase NA Completed
NCT03091803 2021-04-05
QSM and Regional DCE MRI Permeability Using GOCART Technique
University of Southern California
Withdrawn
NCT00395863 2020-11-05
Multihance at 3 Tesla (3T) in Brain Tumors
Bracco Diagnostics, Inc
Phase 4 Completed
NCT03147989 2018-07-18
Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients
Bracco Diagnostics, Inc
Completed
NCT00539253 2017-09-26
TACE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT02967380 2017-03-27
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases
University of Southern California
Phase NA Terminated
NCT02226666 2017-01-13
Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
University of Michigan
Completed
NCT02291822 2016-07-19
Retrospective Study of MRI in Pediatric Patients
Bracco Diagnostics, Inc
Completed
NCT00486473 2010-07-15
DETECT
Bracco Diagnostics, Inc
Phase 3 Completed